恒逸石化(000703.SZ):擬以3.15億元購買恒逸瀚霖25%股權
格隆匯9月23日丨恒逸石化(000703.SZ)公佈,為順應監管形勢,實現資源集中管理,推進總部創新中心建設,加快公司職業化、國際化、創新化人才引進進程,滿足公司未來戰略發展及公司產業鏈整體佈局的要求,恒逸石化股份有限公司擬以現金方式購買浙江恒逸集團有限公司(以下簡稱“恒逸集團”)持有的浙江恒逸瀚霖企業管理有限公司(以下簡稱“恒逸瀚霖”)25%股權。收購總價款參照標的公司在評估基準日2024年8月31日的評估價值,確定25%股權的最終實際成交價格按照3.15億元執行,恒逸石化以現金方式支付。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.